Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy
Julia Lai-Kwon, Sarah Heynemann, Jacinthe Flore, Haryana Dhillon, Mary Duffy, John Burke, Lisa Briggs, Lillian Leigh, Linda Mileshkin, Benjamin Solomon, David Ball, Renata Kokanovic, Michael Jefford
Journal of Cancer Survivorship | SPRINGER | Published : 2021
PURPOSE: Immunotherapy (IT) and targeted therapy (TT) have improved survival for some patients with metastatic non-small cell lung cancer (NSCLC). Their lived experience is under-studied. We conducted a single centre, qualitative study to understand concerns and unmet needs amongst this novel survivor population. METHODS: Eligible participants had metastatic NSCLC, aged >18, English-speaking and >6 months post initiation of IT/TT without progressive disease. Semi-structured interviews focused on physical, psychological, social and functional impacts of diagnosis, therapy and prognosis. Interviews were recorded and transcribed. Data were analysed via qualitative thematic analysis. RESULTS: Be..View full abstract
This work was funded by a research grant from the Lung Service, Peter MacCallum Cancer Centre.